Since PTH inhibits phosphate reabsorption and induces 25-dihydroxy vitamin D 1-α-hydroxylase (Cyp27b1) mRNA expression through the cAMP-dependent cellular mechanism, patients may develop not only hyperphosphatemia but also hypocalcemia. The gene discussed is PTH; the disease is Hypocalcemia.